Accessibility Menu
Protect Pharmaceutical logo

Protect Pharmaceutical

(OTC) PRTT

Current Price$0.25
Market Cap$15.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-99%
5 Year-78%
1 Year-48%
1 Month+145%

Protect Pharmaceutical Financials at a Glance

Market Cap

$15.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$81.73M

Net Income (TTM)

$23.25M

EPS (TTM)

$0.86

P/E Ratio

0.31

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$0.25

Volume

39,200

Open

$0.26

Previous Close

$0.27

Daily Range

$0.25 - $0.26

52-Week Range

$0.02 - $0.87

Estimated Earnings Date

Jul 8, 2024

PRTT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Protect Pharmaceutical

Industry

Pharmaceuticals

CEO

Boris Stepanov

Headquarters

Las Vegas, NV 89115, US

PRTT Financials

Key Financial Metrics (TTM)

Gross Margin

55.70%

Operating Margin

33.55%

Net Income Margin

25.17%

Return on Equity

1.93%

Return on Capital

-0.00%

Return on Assets

1.57%

Earnings Yield

3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

57.45M

Volume

39.20K

Avg. Volume

17.57K

Financials (TTM)

Gross Profit

$45.08M

Operating Income

$27.84M

EBITDA

$27.84M

Operating Cash Flow

$6.18M

Capital Expenditure

-$3.49M

Free Cash Flow

$2.69M

Cash & ST Invst.

$75.76M

Total Debt

$4.41M

Protect Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$15.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$25.85K

N/A

Employees

600

N/A

Net Income

-$1.50K

-100.0%

EBITDA

-$1.50K

-100.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$75.76M

+20.2%

Total Debt

$4.41M

+14.1%

Accounts Receivable

$60.64M

-12.7%

Inventory

$124.77M

+50.3%

Long Term Debt

$0.00

N/A

Short Term Debt

$4.41M

+14.1%

Return on Assets

1.57%

N/A

Return on Invested Capital

2.55%

N/A

Free Cash Flow

-$4.57M

-276.9%

Operating Cash Flow

-$2.10M

-181.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ETCCEnvironmental Tectonics Corporation
$1.55-18.85%
CVVIFSociedad Comercial del Plata S.A.
$0.00-98.79%
QUTIFQuestor Technology Inc.
$0.28+0.00%
CRWECrown Equity Holdings Inc.
$0.43+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ATAIAtaiBeckley
$7.13+0.33%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%
AALAmerican Airlines Group
$15.80+0.01%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$28.32-0.09%

Questions About PRTT

What is the current price of Protect Pharmaceutical?

Protect Pharmaceutical is trading at $0.25 per share.

What is the 52-week range for Protect Pharmaceutical?

Over the past 52 weeks, Protect Pharmaceutical has traded between $0.02 and $0.87.

How much debt does Protect Pharmaceutical have?

As of the most recent reporting period, Protect Pharmaceutical reported total debt of $4.50K.

How much cash does Protect Pharmaceutical have on hand?

Protect Pharmaceutical reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Protect Pharmaceutical’s dividend yield?

Protect Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.